insights_auto
Bakit tumaas ang EBS 3.91%?
Tingnan ang Higit pang Detalyechevron_right
EBS:NYSE
Emergent Biosolutions Inc
$7.18
arrow_upward
+3.91%(+0.27) 1D
$7.18
arrow_downward
-0.04% (-0.0028)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 15, 4:00:03 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EBS...
Buksan
$6.96
Mataas
$7.22
Mababa
$6.84
Mkt. cap
368.14M
Avg. na dami
1.13M
Dami
654.82K
Mataas nang 52-wk
$14.06
Mababa nang 52-wk
$4.36
EPS
-$3.51
Beta
2.28
Mga natitirang share
51.27M
Bilang ng mga empleyado
900
Buksan
$6.96
Mataas
$7.22
Mababa
$6.84
Mkt. cap
368.14M
Avg. na dami
1.13M
Dami
654.82K
Mataas nang 52-wk
$14.06
Mababa nang 52-wk
$4.36
EPS
-$3.51
Beta
2.28
Mga natitirang share
51.27M
Bilang ng mga empleyado
900
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
5 oras ang nakalipas
Emergent BioSolutions stock rises 3.91 percent with USD 368.1 million value
Business Wire
·
13 oras ang nakalipas
Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Tungkol sa Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Mga Empleyado900
ItinatagSet 5, 1998
HeadquartersRockville, Maryland, Estados Unidos
Sektor-
Websiteemergentbiosolutions.com